Associated Papers
Enhanced response to dabrafenib plus trametinib in a patient with BRAF V600E lung cancer harboring an RNF43 variant of unknown significance: a case report.
D'Argento E et al.
Frontiers in Oncology, 2025
Select a paper to view details